{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:37:36Z","timestamp":1793889456318,"version":"4.8.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the remarkable advances due to the discovery and development of antimicrobials agents, infectious diseases remain the second leading cause of death worldwide. This fact underlines the importance of developing new therapeutic strategies to address the widespread antibiotic resistance, which is the major contributing factor for clinical failures of the current therapeutics. In a screen for antibiotic adjuvants, we identified a natural product from actinomycetes, venturicidin A (VentA), that potentiates the aminoglycoside antibiotic gentamicin against multidrug-resistant clinical isolates of <jats:italic>Staphylococcus<\/jats:italic>, <jats:italic>Enterococcus<\/jats:italic>, and <jats:italic>Pseudomonas aeruginosa<\/jats:italic>. Furthermore, the combination of gentamicin and VentA was bactericidal and rapidly eradicated methicillin-resistant <jats:italic>S. aureus<\/jats:italic> (MRSA). The molecular mechanism of gentamicin potentiation activity is attributed to uncoupling of ATP synthesis by VentA from electron transport presumably by blocking the proton flow through ATP synthase, which results in an elevated concentration of extracellular protons and subsequent anticipated raise in gentamicin uptake. The disruption of the proton flux was characterized by perturbed membrane potential in MRSA. These results demonstrate that inhibition of ATP synthase along with the subsequent membrane dysregulation, as shown here with VentA, complements aminoglycoside antibiotics against MDR bacteria, and that this approach may be employed to combat bacterial resistance.<\/jats:p>","DOI":"10.1038\/s41598-020-64756-0","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T10:02:50Z","timestamp":1589796170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Venturicidin A, A Membrane-active Natural Product Inhibitor of ATP synthase Potentiates Aminoglycoside Antibiotics"],"prefix":"10.1038","volume":"10","author":[{"given":"Venkateswarlu","family":"Yarlagadda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"64756_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature17042","volume":"529","author":"ED Brown","year":"2016","unstructured":"Brown, E. D. & Wright, G. D. Antibacterial drug discovery in the resistance era. Nature 529, 336\u2013343 (2016).","journal-title":"Nature"},{"key":"64756_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu, Y. Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161\u2013168 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"64756_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cid\/cir202","volume":"53","author":"N Gupta","year":"2011","unstructured":"Gupta, N., Limbago, B. M., Patel, J. B. & Kallen, A. J. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53, 60\u201367 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"64756_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/AAC.01020-10","volume":"55","author":"D Marchaim","year":"2011","unstructured":"Marchaim, D. et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob. Agents Chemother. 55, 593\u2013599 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64756_CR5","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/jac\/dky188","volume":"73","author":"LM Deshpande","year":"2018","unstructured":"Deshpande, L. M., Castanheira, M., Flamm, R. K. & Mendes, R. E. Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program. J. Antimicrob. Chemother. 73, 2314\u20132322 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"64756_CR6","unstructured":"World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Accessed October 18, 2019, http:\/\/www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en\/."},{"key":"64756_CR7","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/jac\/dky019","volume":"73","author":"N Jackson","year":"2018","unstructured":"Jackson, N., Czaplewski, L. & Piddock, L. J. V. Discovery and development of new antibacterial drugs: learning from experience? J. Antimicrob. Chemother. 73, 1452\u20131459 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"64756_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","volume":"17","author":"M Tyers.","year":"2019","unstructured":"Tyers., M. & Wright, G. D. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat. Rev. Microbiol. 17, 141\u2013155 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"64756_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0002-9343(83)90088-8","volume":"75","author":"RC Moellering Jr.","year":"1983","unstructured":"Moellering, R. C. Jr. Rationale for use of antimicrobial combinations. Am. J. Med. 75, 4\u20138 (1983).","journal-title":"Am. J. Med."},{"key":"64756_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","volume":"24","author":"GD Wright","year":"2016","unstructured":"Wright, G. D. Antibiotic adjuvants: rescuing antibiotics from resistance. Trends Microbiol. 24, 862\u2013871 (2016).","journal-title":"Trends Microbiol."},{"key":"64756_CR11","doi-asserted-by":"publisher","first-page":"pii: a027029","DOI":"10.1101\/cshperspect.a027029","volume":"6","author":"KM Krause","year":"2016","unstructured":"Krause, K. M., Serio, A. W., Kane, T. R. & Connolly, L. E. Aminoglycosides: an overview. Cold Spring Harb. Perspect. Med. 6, pii: a027029 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"64756_CR12","first-page":"93","volume":"1","author":"J Davies","year":"1965","unstructured":"Davies, J., Gorini, L. & Davis, B. D. Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol. Pharmacol. 1, 93\u2013106 (1965).","journal-title":"Mol. Pharmacol."},{"key":"64756_CR13","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1128\/AAC.44.12.3249-3256.2000","volume":"44","author":"LP Kotra","year":"2000","unstructured":"Kotra, L. P., Haddad, J. & Mobashery, S. Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother. 44, 3249\u20133256 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64756_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/C5MD00344J","volume":"7","author":"S Garneau-Tsodikova","year":"2016","unstructured":"Garneau-Tsodikova, S. & Labby, K. J. Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives. Medchemcomm 7, 11\u201327 (2016).","journal-title":"Medchemcomm"},{"key":"64756_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","volume":"13","author":"MS Ramirez","year":"2010","unstructured":"Ramirez, M. S. & Tolmasky, M. E. Aminoglycoside modifying enzymes. Drug Resist. Updat. 13, 151\u2013171 (2010).","journal-title":"Drug Resist. Updat."},{"key":"64756_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"XZ Li","year":"2015","unstructured":"Li, X. Z., Pl\u00e9siat, P. & Nikaido, H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28, 337\u2013418 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"64756_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/CMR.00069-15","volume":"29","author":"BC Kahl","year":"2016","unstructured":"Kahl, B. C., Becker, K. & L\u00f6ffler, B. Clinical significance and pathogenesis of Staphylococcal small colony variants in persistent infections. Clin. Microbiol. Rev. 29, 401\u2013427 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"64756_CR18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/acsinfecdis.8b00001","volume":"4","author":"G Cox","year":"2018","unstructured":"Cox, G. et al. Plazomicin retains antibiotic activity against most aminoglycoside modifying enzymes. ACS Infect. Dis. 4, 980\u2013987 (2018).","journal-title":"ACS Infect. Dis."},{"key":"64756_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10069","volume":"473","author":"KR Allison","year":"2011","unstructured":"Allison, K. R., Brynildsen, M. P. & Collins, J. J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473, 216\u2013220 (2011).","journal-title":"Nature"},{"key":"64756_CR20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/infdis\/jiu286","volume":"210","author":"D Lebeaux","year":"2014","unstructured":"Lebeaux, D. et al. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. J. Infect. Dis. 210, 1357\u20131366 (2014).","journal-title":"J. Infect. Dis."},{"key":"64756_CR21","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1128\/AAC.03069-15","volume":"60","author":"K Poole","year":"2016","unstructured":"Poole, K. et al. Potentiation of aminoglycoside activity in Pseudomonas aeruginosa by targeting the AmgRS envelope stress-responsive two-component system. Antimicrob. Agents Chemother. 60, 3509\u20133518 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64756_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/jac\/dkr510","volume":"67","author":"G Mitchell","year":"2012","unstructured":"Mitchell, G. et al. Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression. J. Antimicrob. Chemother. 67, 559\u2013568 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"64756_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijantimicag.2018.06.005","volume":"52","author":"K N\u00f8hr-Meldgaard","year":"2018","unstructured":"N\u00f8hr-Meldgaard, K., Ovsepian, A., Ingmer, H. & Vestergaard, M. Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus. Int. J. Antimicrob. Agents 52, 390\u2013396 (2018).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"64756_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nature13445","volume":"510","author":"AM King","year":"2014","unstructured":"King, A. M. et al. Aspergillomarasmine A overcomes metallo-\u03b2-lactamase antibiotic resistance. Nature 510, 503\u2013506 (2014).","journal-title":"Nature"},{"key":"64756_CR25","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/jac\/dku057","volume":"69","author":"G Cox","year":"2014","unstructured":"Cox, G., Koteva, K. & Wright, G. D. An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria. J. Antimicrob. Chemother. 69, 1844\u20131855 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"64756_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/192952a0","volume":"192","author":"A Rhodes","year":"1961","unstructured":"Rhodes, A., Fantes, K. H., Boothroyd, B., McGonaglemp & Crosse, R. Venturicidin: a new antifungal antibiotic of potential use in agriculture. Nature 192, 952\u2013954 (1961).","journal-title":"Nature"},{"key":"64756_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ja.2013.113","volume":"67","author":"KA Shaaban","year":"2014","unstructured":"Shaaban, K. A. et al. Venturicidin C, a new 20-membered macrolide produced by Streptomyces sp. TS-2-2. J. Antibiot. (Tokyo) 67, 223\u2013230 (2014).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"64756_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/0005-2728(85)90254-3","volume":"807","author":"DS Perlin","year":"1985","unstructured":"Perlin, D. S., Latchney, L. R. & Senior, A. E. Inhibition of Escherichia coli H+-ATPase by venturicidin, oligomycin and ossamycin. Biochim. Biophys. Acta. 807, 238\u2013244 (1985).","journal-title":"Biochim. Biophys. Acta."},{"key":"64756_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0014-5793(89)80653-2","volume":"249","author":"M Galanis","year":"1989","unstructured":"Galanis, M., Mattoon, J. R. & Nagley, P. Amino acid substitutions in mitochondrial ATP synthase subunit 9 of Saccharomyces cerevisiae leading to venturicidin or ossamycin resistance. FEBS Lett. 249, 333\u2013336 (1989).","journal-title":"FEBS Lett."},{"key":"64756_CR30","doi-asserted-by":"publisher","first-page":"D566","DOI":"10.1093\/nar\/gkw1004","volume":"45","author":"B Jia","year":"2017","unstructured":"Jia, B. et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 45, D566\u2013D573 (2017).","journal-title":"Nucleic Acids Res."},{"key":"64756_CR31","doi-asserted-by":"publisher","first-page":"pii: e01114","DOI":"10.1128\/mBio.01114-17","volume":"8","author":"M Vestergaard","year":"2017","unstructured":"Vestergaard, M. et al. Inhibition of the ATP synthase eliminates the intrinsic resistance of Staphylococcus aureus towards polymyxins. MBio 8, pii: e01114\u201317 (2017).","journal-title":"MBio"},{"key":"64756_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jac\/dkl216","volume":"58","author":"JA Schafer","year":"2006","unstructured":"Schafer, J. A., Hovde, L. B. & Rotschafer, J. C. Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM). J. Antimicrob. Chemother. 58, 108\u2013111 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"64756_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0014-5793(83)80259-2","volume":"156","author":"JP Armitage","year":"1983","unstructured":"Armitage, J. P. & Evans, M. C. The motile and tactic behaviour of Pseudomonas aeruginosa in anaerobic environments. FEBS Lett. 156, 113\u2013118 (1983).","journal-title":"FEBS Lett."},{"key":"64756_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/MMBR.51.4.439-457.1987","volume":"51","author":"HW Taber","year":"1987","unstructured":"Taber, H. W., Mueller, J. P., Miller, P. F. & Arrow, A. S. Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51, 439\u2013457 (1987).","journal-title":"Microbiol. Rev."},{"key":"64756_CR35","unstructured":"Venturicidin A, safety data sheet; Cayman Chemical Company: Ann Arbor, MI, Dec 11, 2015, https:\/\/www.caymanchem.com\/msdss\/15377m.pdf (Accessed October 18th, 2019)."},{"key":"64756_CR36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1021\/acsinfecdis.8b00349","volume":"5","author":"JL Markley","year":"2019","unstructured":"Markley, J. L. et al. Semisynthetic analogues of anhydrotetracycline as inhibitors of tetracycline destructase enzymes. ACS Infect. Dis. 5, 618\u2013633 (2019).","journal-title":"ACS Infect. Dis."},{"key":"64756_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nchembio.559","volume":"7","author":"L Ejim","year":"2011","unstructured":"Ejim, L. et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 7, 348\u2013350 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"64756_CR38","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nmicrobiol.2017.28","volume":"2","author":"JM Stokes","year":"2017","unstructured":"Stokes, J. M. et al. Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance. Nat. Microbiol. 2, 17028 (2017).","journal-title":"Nat. Microbiol."},{"key":"64756_CR39","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1021\/acsinfecdis.8b00103","volume":"4","author":"BM Minrovic","year":"2018","unstructured":"Minrovic, B. M., Jung, D., Melander, R. J. & Melander, C. New class of adjuvants enables lower dosing of colistin against Acinetobacter baumannii. ACS Infect. Dis. 4, 1368\u20131376 (2018).","journal-title":"ACS Infect. Dis."},{"key":"64756_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep28168","volume":"6","author":"JH Chung","year":"2016","unstructured":"Chung, J. H., Bhat, A., Kim, C. J., Yong, D. & Ryu, C. M. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii. Sci. Rep. 6, 28168 (2016).","journal-title":"Sci. Rep."},{"key":"64756_CR41","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1128\/AAC.18.5.722","volume":"18","author":"MH Miller","year":"1980","unstructured":"Miller, M. H., Edberg, S. C., Mandel, L. J., Behar, C. F. & Steigbigel, N. H. Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 18, 722\u2013729 (1980).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64756_CR42","doi-asserted-by":"crossref","unstructured":"Toei, M. & Noji, H. Single-molecule analysis of F0F1-ATP synthase inhibited by N,N-dicyclohexylcarbodiimide. J. Biol. Chem. 288, 25717\u201325726 (2013).","DOI":"10.1074\/jbc.M113.482455"},{"key":"64756_CR43","doi-asserted-by":"publisher","first-page":"13961","DOI":"10.1073\/pnas.1207912109","volume":"109","author":"J Symersky","year":"2012","unstructured":"Symersky, J., Osowski, D., Walters, D. E. & Mueller, D. M. Oligomycin frames a common drug-binding site in the ATP synthase. Proc. Natl. Acad. Sci. USA. 109, 13961\u201313965 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"64756_CR44","doi-asserted-by":"publisher","first-page":"e02197","DOI":"10.1128\/AAC.02197-17","volume":"62","author":"M Lamontagne Boulet","year":"2018","unstructured":"Lamontagne Boulet, M. et al. Tomatidine is a lead antibiotic molecule that targets Staphylococcus aureus ATP synthase subunit C. Antimicrob. Agents Chemother. 62, e02197\u201317 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64756_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1128\/CMR.1.2.139","volume":"1","author":"GM Eliopoulos","year":"1988","unstructured":"Eliopoulos, G. M. & Eliopoulos, C. T. Antibiotic combinations: should they be tested? Clin. Microbiol. Rev. 1, 139\u2013156 (1988).","journal-title":"Clin. Microbiol. Rev."},{"key":"64756_CR46","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1128\/AAC.00785-12","volume":"56","author":"PA Smith","year":"2012","unstructured":"Smith, P. A. & Romesberg, F. E. Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition. Antimicrob. Agents Chemother. 56, 5054\u20135060 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64756_CR47","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1093\/jac\/dkx296","volume":"72","author":"A Mikalauskas","year":"2017","unstructured":"Mikalauskas, A., Parkins, M. D. & Poole, K. Rifampicin potentiation of aminoglycoside activity against cystic fibrosis isolates of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 72, 3349\u20133352 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"64756_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.micpath.2016.03.009","volume":"95","author":"EFF Matias","year":"2016","unstructured":"Matias, E. F. F. et al. Potentiation of antibiotic activity of aminoglycosides by natural products from Cordia verbenacea DC. Microb. Pathog. 95, 111\u2013116 (2016).","journal-title":"Microb. Pathog."},{"key":"64756_CR49","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.chembiol.2019.07.009","volume":"26","author":"LC Radlinski","year":"2019","unstructured":"Radlinski, L. C. et al. Chemical induction of aminoglycoside uptake overcomes antibiotic tolerance and resistance in Staphylococcus aureus. Cell. Cell Chem. Biol. 26, 1355\u20131364 (2019).","journal-title":"Cell Chem. Biol."},{"key":"64756_CR50","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1574-6976.2011.00290.x","volume":"36","author":"H Nikaido","year":"2012","unstructured":"Nikaido, H. & Pag\u00e8s, J. M. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol. Rev. 36, 340\u2013363 (2012).","journal-title":"FEMS Microbiol. Rev."},{"key":"64756_CR51","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1074-5521(01)00051-5","volume":"8","author":"DD Boehr","year":"2001","unstructured":"Boehr, D. D., Lane, W. S. & Wright, G. D. Active site labeling of the gentamicin resistance enzyme AAC(6\u2032)-APH(2\u2033) by the lipid kinase inhibitor wortmannin. Chem. Biol. 8, 791\u2013800 (2001).","journal-title":"Chem. Biol."},{"key":"64756_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nature22308","volume":"545","author":"MF Richter","year":"2017","unstructured":"Richter, M. F. et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545, 299\u2013304 (2017).","journal-title":"Nature"},{"key":"64756_CR53","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/clinchem\/23.10.1838","volume":"23","author":"GW Peng","year":"1977","unstructured":"Peng, G. W. et al. High-pressure liquid-chromatographic method for determination of gentamicin in plasma. Clin. Chem. 23, 1838\u20131844 (1977).","journal-title":"Clin. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64756-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:20:12Z","timestamp":1670325612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64756-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64756"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64756-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"22 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8134"}}